Review of recent guidelines and consensus statements on hereditary angioedema therapy with focus on self-administration

M. Cicardi, Timothy Craig, I. Martinez-Saguer, J. Hébert, H. J. Longhurst

Research output: Contribution to journalReview article

28 Citations (Scopus)

Abstract

Consensus meetings and the resulting recommendations shape treatment choices in rare diseases such as hereditary angioedema (HAE) because they combine the experience of prescribing physicians and the patients who are receiving therapy. Self-administration of HAE therapy was recognised as a potential treatment option in the first consensus publication in 2003. Recent studies have confirmed that self-administration of therapy resolves attacks quickly, safely and minimises burden of disease; however, the discovery of inconsistent treatment approaches is a concern and warrants investigation into the barriers that prevent adherence with current recommendations.

Original languageEnglish (US)
Pages (from-to)3-9
Number of pages7
JournalInternational Archives of Allergy and Immunology
Volume161
Issue numberSUPPL.1
DOIs
StatePublished - May 1 2013

Fingerprint

Hereditary Angioedemas
Self Administration
Guidelines
Therapeutics
Rare Diseases
Publications
Physicians

All Science Journal Classification (ASJC) codes

  • Immunology and Allergy
  • Immunology

Cite this

@article{9dbbde45f150415b8b06623da5d7ac2e,
title = "Review of recent guidelines and consensus statements on hereditary angioedema therapy with focus on self-administration",
abstract = "Consensus meetings and the resulting recommendations shape treatment choices in rare diseases such as hereditary angioedema (HAE) because they combine the experience of prescribing physicians and the patients who are receiving therapy. Self-administration of HAE therapy was recognised as a potential treatment option in the first consensus publication in 2003. Recent studies have confirmed that self-administration of therapy resolves attacks quickly, safely and minimises burden of disease; however, the discovery of inconsistent treatment approaches is a concern and warrants investigation into the barriers that prevent adherence with current recommendations.",
author = "M. Cicardi and Timothy Craig and I. Martinez-Saguer and J. H{\'e}bert and Longhurst, {H. J.}",
year = "2013",
month = "5",
day = "1",
doi = "10.1159/000351232",
language = "English (US)",
volume = "161",
pages = "3--9",
journal = "International Archives of Allergy and Immunology",
issn = "1018-2438",
publisher = "S. Karger AG",
number = "SUPPL.1",

}

Review of recent guidelines and consensus statements on hereditary angioedema therapy with focus on self-administration. / Cicardi, M.; Craig, Timothy; Martinez-Saguer, I.; Hébert, J.; Longhurst, H. J.

In: International Archives of Allergy and Immunology, Vol. 161, No. SUPPL.1, 01.05.2013, p. 3-9.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Review of recent guidelines and consensus statements on hereditary angioedema therapy with focus on self-administration

AU - Cicardi, M.

AU - Craig, Timothy

AU - Martinez-Saguer, I.

AU - Hébert, J.

AU - Longhurst, H. J.

PY - 2013/5/1

Y1 - 2013/5/1

N2 - Consensus meetings and the resulting recommendations shape treatment choices in rare diseases such as hereditary angioedema (HAE) because they combine the experience of prescribing physicians and the patients who are receiving therapy. Self-administration of HAE therapy was recognised as a potential treatment option in the first consensus publication in 2003. Recent studies have confirmed that self-administration of therapy resolves attacks quickly, safely and minimises burden of disease; however, the discovery of inconsistent treatment approaches is a concern and warrants investigation into the barriers that prevent adherence with current recommendations.

AB - Consensus meetings and the resulting recommendations shape treatment choices in rare diseases such as hereditary angioedema (HAE) because they combine the experience of prescribing physicians and the patients who are receiving therapy. Self-administration of HAE therapy was recognised as a potential treatment option in the first consensus publication in 2003. Recent studies have confirmed that self-administration of therapy resolves attacks quickly, safely and minimises burden of disease; however, the discovery of inconsistent treatment approaches is a concern and warrants investigation into the barriers that prevent adherence with current recommendations.

UR - http://www.scopus.com/inward/record.url?scp=84877975489&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84877975489&partnerID=8YFLogxK

U2 - 10.1159/000351232

DO - 10.1159/000351232

M3 - Review article

C2 - 23689238

AN - SCOPUS:84877975489

VL - 161

SP - 3

EP - 9

JO - International Archives of Allergy and Immunology

JF - International Archives of Allergy and Immunology

SN - 1018-2438

IS - SUPPL.1

ER -